Caxton Associates (UK)’s Diebold Nixdorf DBD Stock Holding History

Caxton Associates (UK)’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Buy	+2,918	New	+$215K	0.01%	693

Other funds holding DBD

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MCM

Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BPCM

Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Caxton Associates (UK)'s DBD Position: Q1 2026 in Review

Caxton Associates (UK) opened a new position in Diebold Nixdorf (DBD) in Q1 2026: 2,918 shares worth $220K. The stake represents 0.01% of the portfolio and ranks #693 among its holdings.

201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

Caxton Associates (UK) held 2,918 shares of Diebold Nixdorf worth $220K as of Q1 2026.
Diebold Nixdorf was a new Caxton Associates (UK) position in Q1 2026.
Diebold Nixdorf made up 0.01% of Caxton Associates (UK)'s portfolio in Q1 2026, its #693 holding.
201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.